Immune checkpoint blockade  Anti-PD-1 (vs. Thymosin)  NCT04268537  II  Nanjing, China  120  Respiratory failure within <48h of ICU  Prevent T-cell regulation by blocking PD-1; in COVID19+ advanced or metastatic cancer patients;